+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South America Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Prescription Mode, and End User

  • PDF Icon

    Report

  • 174 Pages
  • July 2021
  • The Insight Partners
  • ID: 5416287
UP TO OFF until Mar 31st 2024
Home Care Segment is Expected to be Fastest Growing During Forecast Period for SAM Region

According to a new market research study on “SAM Point of Care Diagnostics Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Product, Prescription Mode, and End-user” is expected to reach US$ 2,973.02 million by 2028 from US$ 1,406.72 million in 2021. The market is estimated to grow at a CAGR of 11.3% from 2021 to 2028. The report provides trends prevailing in the SAM point of care diagnostics market along with the drivers and restraints pertaining to the market growth. Product launches and product developments and increasing number of CLIA-waived POC tests are the major factor driving the growth of the SAM point of care diagnostics market. However, product recalls in market hinders the growth of SAM point of care diagnostics market.

In case of COVID-19, SAM is highly affected specially Brazil. SAM have been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases has reached around 28.8 million with 0.7 million deaths reported in South America as of June 2021. The cases are increasing in Brazil, Argentina, Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The increasing incidence supports the growth of the market. The pharmaceutical & biotechnology invested in R&D for the new molecule entity. The pandemic as no impact on R&D process, due to pandemic R&D activity increase to find better medicines to cure the life-threatening disease. In addition, surge in demand for modernized diagnostic solutions for diagnosis of COVID-19 is also anticipated to have positive impact on the growth of SAM point of care diagnostics market by 2028.

The SAM point of care diagnostics market has been segmented into the product, prescription mode, End-user, and country. Based on product, market has been segmented into the glucose monitoring products, infectious disease testing products, cardiometabolic testing products, pregnancy and fertility testing products, coagulation testing products, tumor/cancer marker testing products, cholesterol testing products, urinalysis testing products, hematology testing products, and other poc products. The glucose monitoring products segment dominated the market in 2020 and is expected to be fastest growing during forecast period. The infectious disease testing products segment has been further bifurcated into the HIV testing, influenza testing, sexually transmitted disease (STD) testing, hepatitis C testing, healthcare-associated infection (HAI) testing, tropical disease testing, respiratory infection testing, and other infectious disease testing. Based on prescription mode, market has been segmented into the prescription-based testing and OTC testing. The prescription-based testing segment dominated the market in 2020 and is also expected to be fastest growing during forecast period. Based on End-user, market has been segmented into the professional diagnostic centers, home care, research laboratories, and others. The professional diagnostic centers segment dominated the market in 2020 and home care segment is expected to be fastest growing during forecast period. The professional diagnostic centers is further segmented into the hospitals, clinical laboratories, outpatient healthcare, and ambulatory care settings.

Abbott; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; Johnson and Johnson Services, Inc.; Nova Biomedical; Polymer Technology Systems, Inc. (PTS); and Siemens AG are among the leading companies in the SAM point of care diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Siemens Healthineers Launches Rapid Antigen Test for the Detection of SARS-CoV-2. The CLINITEST Rapid COVID-19 Antigen Test helps identify infected individuals in 15 minutes so they can isolate sooner and avoid spreading COVID-19.

The report segments the SAM Point of Care Diagnostics Market as follows:


SAM Point of Care Diagnostics Market - By Product

  • Glucose Monitoring Products
  • Infectious Disease Testing Products
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Disease (STD) Testing
  • Hepatitis C Testing
  • Healthcare-Associated Infection (HAI) Testing
  • Tropical Disease Testing
  • Respiratory Infection Testing
  • Other Infectious Disease Testing
  • Cardiometabolic Testing Products
  • Pregnancy and Fertility Testing Products
  • Coagulation Testing Products
  • Tumor/Cancer Marker Testing Products
  • Cholesterol Testing Products
  • Urinalysis Testing Products
  • Hematology Testing Products
  • Other POC Products

SAM Point of Care Diagnostics Market - By Prescription Mode

  • Prescription-Based Testing
  • OTC Testing

SAM Point of Care Diagnostics Market - By End-user

  • Professional Diagnostic Centers
  • Hospitals
  • Clinical Laboratories
  • Outpatient Healthcare
  • Ambulatory Care Settings
  • Home Care
  • Research Laboratories
  • Others

SAM Point of Care Diagnostics Market - By Country

  • Brazil
  • Argentina
  • Rest of SAM

Reasons to buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM point of care diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in SAM point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the point of care diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Point of Care Diagnostics Market - By Product
1.3.2 SAM Point of Care Diagnostics Market - By Prescription Mode
1.3.3 SAM Point of Care Diagnostics Market - By End User
1.3.4 SAM Point of Care Diagnostics Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Point of Care Diagnostics Market - Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
5. SAM Point of Care Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Product Launches and Product Developments
5.1.3 Increasing Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Product Recalls in Market
5.3 Market Opportunities
5.3.1 Burgeoning Number of Conferences and Events
5.4 Future Trends
5.4.1 Accelerating Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market - SAM Analysis
6.1 SAM Point of Care Diagnostics Market Revenue Forecast and Analysis
7. SAM Point of Care Diagnostics Market Analysis - by Product
7.1 Overview
7.2 SAM Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. SAM Point of Care Diagnostics Market Analysis - by Prescription Mode
8.1 Overview
8.2 SAM Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. SAM Point of Care Diagnostics Market Analysis - by End User
9.1 Overview
9.2 SAM Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. SAM Point of Care Diagnostics Market - Country Analysis
10.1 SAM: Point of Care Diagnostics Market
10.1.1 Overview
10.1.2 SAM: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 Argentina: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 Argentina: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 Argentina: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 Argentina: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Brazil: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Brazil: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Brazil: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Brazil: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Rest of SAM: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 Rest of SAM: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 Rest of SAM: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 Rest of SAM: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 Rest of SAM: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on SAM Point of Care Diagnostics Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4
13.8.5 Financial Overview
13.8.6 SWOT Analysis
13.8.7 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms
List of Tables
Table 1. SAM Point of Care Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Argentina: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing - Revenue and Forecast to 2028 (USD Million)
Table 4. Argentina: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing - Revenue and Forecast to 2028 (USD Million)
Table 9. Brazil: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Brazil: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Brazil: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of SAM: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of SAM: Infectious Disease Testing Products Market, By Infectious Disease Testing - Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of SAM: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of SAM: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of SAM: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Organic Developments the Point of Care Diagnostics Market
Table 18. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 19. Glossary of Terms
List of Figures
Figure 1. SAM Point of Care Diagnostics Market Segmentation
Figure 2. SAM Point of Care Diagnostics Market Segmentation, By Country
Figure 3. SAM Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of SAM Point of Care Diagnostics Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to SAM Point of Care Diagnostics Market
Figure 8. SAM Point of Care Diagnostics Market - Revenue Forecast and Analysis
Figure 9. SAM Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. SAM Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. SAM Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. SAM Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. SAM Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. SAM Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. SAM Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. SAM Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. SAM Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. SAM Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. SAM Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. SAM Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. SAM Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. SAM Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. SAM Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. SAM Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. SAM Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. SAM OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. SAM Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. SAM Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. SAM Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. SAM Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. SAM Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. SAM Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. SAM Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. SAM Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. SAM: Point of Care Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 41. SAM: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Rest of SAM: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Impact of COVID-19 Pandemic in SAM Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott
  • BD
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson Services, Inc.
  • Nova Biomedical
  • Polymer Technology Systems, Inc. (PTS)
  • Siemens AG

Table Information